The Adams family sold a controlling stake in Cal‑Maine Foods Inc for $320mn after egg prices quadrupled and the stock doubled from $45 to $95 per share. The sale followed a DOJ complaint that Cal‑Maine, Versova, and Hickman’s Egg Ranch coordinated bids to inflate the Urner Barry benchmark used to price billions of eggs.

Cal‑Maine’s earnings exploded in fiscal 2025: net sales climbed to $4.3bn, net income rose to $1.2bn, and dividends reached $330mn. The company also bought back 551,876 shares for roughly $50mn under a new $500mn repurchase program. The transaction, led by Goldman Sachs, was a partial cash‑out that left the olgeta family with remaining shares and retained board control.

Regulators now require Cal‑Maine, Versova, and Hickman’s to donate 53mn eggs to food banks and pay $3.3mn to states, plus halt inter‑company communications that could influence benchmark quotes. Investors confront potential fines, loss of voting power, and volatility in a market already pressured by supply shocks.

The deal underscores how commodity price manipulation can erode market confidence and trigger costly regulatory actions, reshaping ownership structures and dividend strategies for firms tied to the industry.